Clinical trial
Treatment of Thoracic Outlet Syndrome (TOS) With Botox
NCT00444886 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00444886 |
|---|---|
| Title | Treatment of Thoracic Outlet Syndrome (TOS) With Botox |
| Official title | Treatment of Thoracic Outlet Syndrome With Botulinum Toxin Injection: A Double-Blind, Randomized Controlled Trial |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thoracic Outlet Syndrome |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A injection (BOTOX) |
| Enrollment | 40 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Mar 8, 2007 |
| Last update posted | Feb 10, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: